ONDO, ZEC, TON, and BIO surge as supply black holes and short squeezes drive 120% weekly gains

The financial markets have shown diminishing sensitivity to the US-Iran conflict, with most assets recording gains during the first week of May. BTC repeatedly tested the $80,000 resistance level, peaking at $83,000, while the S&P 500 reached new highs and semiconductor stocks followed a parabolic trajectory. Funds flowed into Strategy's STRC ahead of the ex-dividend date. Within the crypto sector, price action has been characterized by specific, extravagant surges rather than a broad vertical uptrend. ZEC doubled in value within a week, hitting a peak of $600 and briefly exceeding a $100 billion market cap. TON surged 120% in seven days, reaching a $7.6 billion market cap and temporarily displacing LINK to enter the top 20. ONDO climbed 50% following news regarding the DTCC working group, rising from $0.18 to approximately $0.4. LAB's fully diluted valuation hit $4.5 billion, while SKYAI multiplied tenfold in a month. Smaller cap assets including LUNC, BIO, STRK, JTO, and PENDLE are also participating in this rally. Despite these movements, the Altcoin Season Index remains stagnant at 39, with BTC dominance holding at 58.8% and only half of the top 100 coins trading above their 50-day moving averages. This indicates that genuine growth is concentrated in a select few assets, while many legacy DeFi tokens and protocol tokens reliant solely on TVL data remain in sideways trends. Data compiled by Woofun AI shows that the current market structure favors assets with specific catalysts over broad sector rotation.

ONDO, a leader in the Real World Assets (RWA) track, surged 57% in the past week to trade around $0.4, driven primarily by two major partnership announcements. On May 4, Ondo was selected to join the Industry Working Group of DTCC, the core financial infrastructure of US capital markets. This group includes financial giants such as BlackRock, Goldman Sachs, JPMorgan, Franklin Templeton, Morgan Stanley, Bank of America, Citadel Securities, NYSE Group, Circle, Fireblocks, and Robinhood. DTCC custodies $114 trillion in assets with an annual clearing volume of $37 trillion, serving as the universal path behind the US securities market. Following a no-action letter from the SEC in late 2025, DTCC plans to launch its tokenization service with limited availability in July 2026 and a full launch in October, initially covering Russell 1000 stocks, major ETFs, and US Treasury bonds. Ondo's inclusion positions it to define the token layer interface for this future standard. Shortly after, on May 6, Ondo, alongside JPMorgan's Kinexys, Mastercard's MTN network, and Ripple, completed the first cross-border tokenized government bond redemption. Ripple redeemed holdings in OUSG, with instructions issued on the XRP Ledger, routing via Mastercard, and fiat settlement by JPMorgan's Kinexys, transferring funds to Ripple's Singapore bank account in just 5 seconds. This contrasts sharply with the traditional 1 to 3 business days required for cross-border settlements. DTCC CEO Frank La Salla stated that tokenization will fundamentally change market operations, echoing BlackRock's Larry Fink's view of it as the market's next evolution. From a data perspective, Ondo now controls approximately 70% of the tokenized stock market, with TVL growing from $26 billion to $35.3 billion. Q1 2026 protocol revenue reached $13.26 million, and the tokenized stock market segment tripled from $375 million in May 2025 to $1.21 billion in May 2026.

ZEC experienced the most significant surge, rising 90% in 30 days and skyrocketing over 30% in a single day on May 6 to touch above $580, surpassing a $10 billion market cap. The catalyst was a disclosure by Multicoin Capital managing partner Tushar Jain during a Consensus Miami panel, followed by a detailed thread revealing quiet accumulation since February. Jain argued that ZEC is the cleanest hedge against increasing government visibility and confiscation capabilities of private wealth, citing potential wealth taxes targeting residents with net worths exceeding $1 billion. He posited that while Bitcoin is censorship-resistant at the protocol layer, tax authorities can still confiscate visible assets, shifting the hedge narrative from currency devaluation to surveillance resistance. This aligns with macro concerns regarding the Trump administration's fiscal and surveillance policies, where "assets being seen is equivalent to assets being taken." ZEC is uniquely positioned compared to Monero due to its support for selective disclosure, allowing opt-in transparency while remaining compliant with MiCA and AML frameworks on exchanges like Coinbase and Gemini. Woofun AI notes that this institutional thesis triggered a chain reaction, with $62 million in ZEC futures shorts liquidated within 24 hours, driving the price from $400 to above $580. Institutional backing is robust; Tyler Winklevoss's Cypherpunk Technologies accumulated 290,000 ZEC by the end of 2025, representing 1.76% of circulating supply, with a public target of 5%. Arthur Hayes has long touted ZEC as the next asymmetric position after BTC, and Barry Silbert of Grayscale suggested 5% to 10% of BTC's market cap could flow into privacy coins. Robinhood listed ZEC on April 23, exposing it to millions of retail accounts, while Grayscale's Zcash Trust has applied to convert to a spot ETF. Structurally, ZEC's shielded pool now accounts for 30% of circulating supply, a historic high, with the Orchard pool growing from 1.92 million to 4.55 million ZEC in a year. This creates a supply black hole where roughly one-third of ZEC is effectively removed from circulation, magnifying marginal buying pressure. The short squeeze, combined with thin liquidity, resulted in a single-day 30% pump, validating a triple positive of institutional buying, retail onramps, and regulatory arbitrage.

BIO, the smallest and most volatile of the four with a $100 million market cap, surged 96% over two days in mid-April from $0.018 to $0.044, currently oscillating around $0.05 with a 176.8% monthly gain. The narrative behind BIO's surge is a mechanistic combination of narrative revival, low float, and short squeeze. The DeSci track has been discussed since 2024, with BIO launching on Binance Launchpool in December 2024 and surging 240% in the first two minutes. Arthur Hayes explicitly turned Maelstrom's risk dial towards DeSci in January 2025, holding seven tokens including BIO. In September 2025, Maelstrom led a $6.9 million seed round for Bio Protocol, co-invested by Mechanism Capital, Animoca Brands, Zee Prime Capital, and Foresight Ventures. Binance Labs also invested in BIO in November 2024.

However, from late 2025 to Q1 2026, BIO plummeted from $0.88 to $0.0157, exacerbated by Binance delisting the BIO/BNB pair on January 9, 2026. The secondary market ignition came from the launchpad sector. In late April, BIO Protocol completed the BioXP V2 upgrade, introducing an ignition sale mechanism where holders earn BioXP points through staking to gain priority access. Uniquely, 100% of ignition sale funds are injected into liquidity pools, creating a buy-back effect for BIO tokens. PeptAI, a peptide AI project within the ecosystem, demonstrated the potential of this model by designing a novel ADHD compound in 24 hours at a cost of $1,500. The first ignition sale was oversubscribed 5.9 times in 30 minutes, with 20% of allocation going to BIO stakers. This mechanism reduced circulating supply as holders locked tokens, leading to an 18.57% price surge and a 697% spike in trading volume, peaking at $223 million in a single day. It is crucial to clarify that Eli Lilly's $300 million acquisition of CrossBridge Bio on April 14 was unrelated to BIO Protocol, a traditional biotech firm. The only indirect link to traditional pharma is Pfizer Ventures' 2022 investment in vitaDAO, a BioDAO within the BIO ecosystem. BIO's surge is driven by the DeSci narrative consolidating after 16 months, extremely low float with trading volumes often 1.5 to 7 times market cap, and a short squeeze. Woofun AI analysis suggests that while BIO carries high risk due to its 96% drop from highs, its positioning as a DeSci token with institutional trust stamps makes it a speculative but clear target in an underpriced sector.

TON saw a 120% increase in a single week, rising from $1.35 to $2.89 and briefly surpassing LINK to enter the top 20 by market cap. The logic centers on Telegram founder Pavel Durov. On April 23, Durov announced a 6x reduction in on-chain transaction fees to 0.00039 TON per transaction, approximately $0.0005, with a fixed rate unaffected by network load. The real trigger occurred on May 4 when Durov announced that Telegram would replace the TON Foundation as the primary driver and largest validator, naming the new setup MTONGA. This marked a shift from the 2020 SEC lawsuit that forced Durov to return $1.2 billion and step away from the project. Telegram's return signifies a transformation from compliance risk to opportunity under the Trump administration's regulatory loosening and the CLARITY Act. Telegram staked 2.2 million TON as a validator, effectively tying its 950 million monthly active users to the network. This mechanism, offering over 20% APR, attracts large holders to lock tokens, reducing circulating supply similar to ZEC's shielded pool. Operationally, TON Network processed 1.5 billion transactions in Q1 2026, reaching a TVL of $1.2 billion in April. STON.fi, the largest DEX on TON, saw daily swap volume surge 26x from $1.5 million to $40 million in a week, while Telegram Wallet's perpetual futures monthly volume exceeded $1 billion. The market is responding to the signal that Durov has staked his reputation on TON, shifting its valuation anchor from an L1 project to a consumer-grade payment layer.

Analyzing these four tokens reveals a commonality: each possesses a "circulating supply black hole." Without new retail participants, the market competes for existing supply, and shrinking floats amplify marginal buying pressure. ONDO's DTCC partnership signifies institutional custody, while OUSG tokenized treasury bonds are locked in traditional asset management frameworks. ZEC's shielded pool absorbed 30% of circulating supply, with the Orchard treasury growing significantly. BIO's low market cap and BioXP upgrade further reduced circulation. TON's staking APR and Telegram's validator stake add coins to the validator pool. These mechanisms, though different, result in the same effect: shrinking supply increases elasticity. A second commonality is the short squeeze backdrop. From last year to early this year, altcoins were consensus short targets with negative funding rates. Catalysts triggered short covering, compounded by low liquidity, leading to daily price increases of 30% to 50%. ZEC saw $620 million in short positions liquidated in a week, TON's volume surged 650%, and BIO's volume ranged from 1.5 to 7 times its market cap.

Furthermore, each token has narrative leaders with skin in the game. ONDO is backed by DTCC, BlackRock, and JPMorgan. ZEC is supported by Multicoin, Cypherpunk Technologies, Arthur Hayes, and Naval Ravikant. BIO has direct investment from Arthur Hayes and Binance Labs. TON is backed solely by Durov. Unlike KOL shillers, these holders have their reputations tied to the assets, creating reflexivity. At the macro level, the S&P 500 hitting new highs and semiconductors going parabolic indicate risk-on behavior, overlaid with political anxieties. ONDO represents compliance, ZEC addresses surveillance, BIO tackles research inefficiency, and TON navigates platform regulation. In the absence of a broad altseason, the market rewards assets with specific supporters, shrinking supply, and trapped shorts. This phenomenon can be termed the "Spring of Circulating Supply Black Hole."